A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

PHASE3RecruitingINTERVENTIONAL
Enrollment

780

Participants

Timeline

Start Date

August 21, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

March 31, 2028

Conditions
Chronic Migraine
Interventions
DRUG

Xeomin

Solution for injection prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl)

DRUG

Placebo

Solution for injection prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl)

Trial Locations (30)

11229

RECRUITING

Integrative Clinical Trials, Merz Investigational Site #0010496, Brooklyn

14221

RECRUITING

Upstate Clinical Research Associates, Merz Investigational Site #0010485, Williamsville

29010

RECRUITING

Hospital Regional Universitario de Malaga, Merz Investigational Site #0340050, Málaga

RECRUITING

Hospital Universitario Virgen de la Victoria, Merz Investigational Site #0340056, Málaga

29016

RECRUITING

Hospital Vithas Malaga, Merz Investigational Site #0340054, Málaga

29935

RECRUITING

Coastal Neurology, Merz Investigational Site #0010503, Port Royal

30030

RECRUITING

Accel Research - NeuroStudies, Merz Investigational Site #0010523, Decatur

33157

RECRUITING

American Research Institute, Merz Investigational Site #0010492, Miami

41013

RECRUITING

Hospital Universitario Virgen del Rocio, Merz Investigational Site #0340046, Seville

48127

RECRUITING

Vida Clinical Studies, Merz Investigational Site #0010498, Dearborn Heights

48334

RECRUITING

Quest Research Institute, Merz Investigational Site #0010484, Farmington Hills

50012

RECRUITING

Hospital Viamed Montecanal, Merz Investigational Site #0340053, Zaragoza

66211

RECRUITING

Kansas Institute of Research,, Merz Investigational Site #0010495, Overland Park

68114

RECRUITING

Quality Clinical Research, Merz Investigational Site #0010522, Omaha

70043

RECRUITING

Crescent City Headache and Neurology Center, Merz Investigational Site #0010517, Chalmette

70115

RECRUITING

DelRicht Clinical Research, Merz Investigational Site #0010518, New Orleans

73013

RECRUITING

Tekton Research, Merz Investigational Site #0010494, Edmond

75035

RECRUITING

Lone Star Neurology, Merz Investigational Site #0010497, Frisco

75209

RECRUITING

Alina Clinical Trials, Merz Investigational Site #0010511, Dallas

85018

RECRUITING

Arizona Neuroscience Research, Merz Investigational Site #0010521, Phoenix

90048

RECRUITING

Clinical Research Institute, Merz Investigational Site #0010487, Los Angeles

90067

RECRUITING

BNL Health, Merz Investigational Site #0010501, Los Angeles

06905

RECRUITING

New England Institute Neurology and Headache, Merz Investigational Site #0010441, Stamford

01581

RECRUITING

Mass Institute of Clinical Research, Merz Investigational Site #0010506, Westborough

85-752

RECRUITING

AthleticoMed, Merz Investigational Site #0480127, Bydgoszcz

39-200

RECRUITING

ETG Debica, Merz Investigational Site #0480121, Dębica

20-412

RECRUITING

ETG Lublin, Merz Investigational Site #0480118, Lublin

02-677

RECRUITING

ETG Neuroscience, Merz Investigational Site #0480116, Warsaw

22-400

RECRUITING

ETG Zamosc, Merz Investigational Site #0480120, Zamość

08006

RECRUITING

Hospital Clinic de Barcelona-Hospital Plato, Merz Investigational Site #0340047, Barcelona

Sponsors
All Listed Sponsors
lead

Merz Therapeutics GmbH

INDUSTRY

NCT07018713 - A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine | Biotech Hunter | Biotech Hunter